A negative correlation between the expression of ANXA9 and the miR-186-5p level was demonstrated by applying ENCORI analysis (http://starbase.sysu.edu.cn/index.php) of a public dataset including in 1085 breast cancer patients (Figure 6A). Here, ANXA9 is linked to breast cancer.